429 related articles for article (PubMed ID: 29608108)
21. Folate-decorated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting delivery: optimization and in vivo antitumor activity.
Zhang C; Zhang Z; Zhao L
Drug Deliv; 2016 Jun; 23(5):1830-7. PubMed ID: 26652055
[TBL] [Abstract][Full Text] [Related]
22. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
Tong L; Chen W; Wu J; Li H
Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314
[TBL] [Abstract][Full Text] [Related]
23. [Structure-activity relationship of annonaceous acetogenins against multidrug resistant human hepatic carcinoma cell line SMMC-7721/ADR].
Wang XN; Li X; Chen Y; Li Y
Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2518-2523. PubMed ID: 28840693
[TBL] [Abstract][Full Text] [Related]
24. Quantification of DOX bioavailability in biological samples of mice by sensitive and precise HPLC assay.
Zhang C; Wu Y; Dong Y; Xu H; Zhao L
Pharm Biol; 2016; 54(1):55-61. PubMed ID: 25880143
[TBL] [Abstract][Full Text] [Related]
25. Acetogenins as Potential Anticancer Agents.
Mangal M; Khan MI; Agarwal SM
Anticancer Agents Med Chem; 2015; 16(2):138-59. PubMed ID: 26118710
[TBL] [Abstract][Full Text] [Related]
26. Surface-Modified Nanoerythrocyte Loading DOX for Targeted Liver Cancer Chemotherapy.
Wang Y; Chen X; He D; Zhou Y; Qin L
Mol Pharm; 2018 Dec; 15(12):5728-5740. PubMed ID: 30359027
[TBL] [Abstract][Full Text] [Related]
27. Antitumor activity of annonaceous acetogenins in HepS and S180 xenografts bearing mice.
Chen Y; Chen JW; Xu SS; Wang Y; Li X; Cai BC; Fan NB
Bioorg Med Chem Lett; 2012 Apr; 22(8):2717-9. PubMed ID: 22446092
[TBL] [Abstract][Full Text] [Related]
28. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and Cytotoxic Property of Annonaceous Acetogenin Glycoconjugates.
Shi JF; Wu P; Cheng XL; Wei XY; Jiang ZH
Drug Des Devel Ther; 2020; 14():4993-5004. PubMed ID: 33235438
[TBL] [Abstract][Full Text] [Related]
30. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
[TBL] [Abstract][Full Text] [Related]
31. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A
J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007
[TBL] [Abstract][Full Text] [Related]
32. New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation.
Rosière R; Van Woensel M; Gelbcke M; Mathieu V; Hecq J; Mathivet T; Vermeersch M; Van Antwerpen P; Amighi K; Wauthoz N
Mol Pharm; 2018 Mar; 15(3):899-910. PubMed ID: 29341619
[TBL] [Abstract][Full Text] [Related]
33. Four cytotoxic annonaceous acetogenins from the seeds of Annona squamosa.
Miao Y; Xu X; Yuan F; Shi Y; Chen Y; Chen J; Li X
Nat Prod Res; 2016 Jun; 30(11):1273-9. PubMed ID: 26181648
[TBL] [Abstract][Full Text] [Related]
34. Photothermal combined with intratumoral injection of annonaceous acetogenin nanoparticles for breast cancer therapy.
Zuo C; Zou Y; Gao G; Sun L; Yu B; Guo Y; Wang X; Han M
Colloids Surf B Biointerfaces; 2022 May; 213():112426. PubMed ID: 35219964
[TBL] [Abstract][Full Text] [Related]
35. Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres.
Shen Z; Li Y; Kohama K; Oneill B; Bi J
Pharmacol Res; 2011 Jan; 63(1):51-8. PubMed ID: 21035550
[TBL] [Abstract][Full Text] [Related]
36. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
[TBL] [Abstract][Full Text] [Related]
37. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
38. Preparation of hydroxy genkwanin nanosuspensions and their enhanced antitumor efficacy against breast cancer.
Ao H; Li Y; Li H; Wang Y; Han M; Guo Y; Shi R; Yue F; Wang X
Drug Deliv; 2020 Dec; 27(1):816-824. PubMed ID: 32489130
[TBL] [Abstract][Full Text] [Related]
39. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
Lin M; Teng L; Wang Y; Zhang J; Sun X
Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
[TBL] [Abstract][Full Text] [Related]
40. Polypeptide-based Micelles for Delivery of Irinotecan: Physicochemical and In vivo Characterization.
Ramasamy T; Choi JY; Cho HJ; Umadevi SK; Shin BS; Choi HG; Yong CS; Kim JO
Pharm Res; 2015 Jun; 32(6):1947-56. PubMed ID: 25471199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
